You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0010 Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: results from the 12-month primary analysis of a randomized, double-blind, active-controlled study

Alerts

Article menu

Download PDFPDF

Oral Presentations
Assessment and management of osteoporosis
OP0010 Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: results from the 12-month primary analysis of a randomized, double-blind, active-controlled study
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address